2022-03-31-accounts - South Tyneside and Sunderland NHS Foundation Trust Charitable Funds

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Contents					~Pa e
Reference	and Administrative			Details ofthe Charity	3 —4
Trustee's	Report				5-22
Statement	ofTrustee's		responsibilities		23
Independent auditor's		report			24 - 27
Foreword					28
Statement	of Financial		Activities		29
Balance Sheet					30
Statement	of Cashflow				31
Statement	ofAccounting		Policies		32 - 36
Notes to the Financial		Statements			37-45

mbers	durin the e	rlod A ril 202	1 to Janua 2023'
Ngozi	Lyn Cole	Chair
David	Barnes	Non-Executive Director - retired 31 March 2022
Hayley Wardle		Executive	Director of Finance from	1 April 2021
Melanic Johnson		Executive	Director of Nursing, Midwifery and AHPs
Anita Hagon		Sunderland	Public Constituency to	30June 2021 and
		reappointed	as Council of Governor	Representative	from
		September	2022
Karen	White	South Tyneside Public Constituency		to June 2022
Joyce	Welsh	South Tyneside Public Constituency		from 1 October
		2021 until	August 2022
Roy McLachlan		Non-Executive Director - from 15August 2022
Martin	Knowles	Non-Executive Director - from 15August 2022
Angela	Thompson	Council of	Governor Representative	from September
		2022

						Total	Total
		Notes	Unrestricted	Restricted	Endowment	2022	2021
			Funds	Funds	Funds	Funds	Funds
			EOOO	f000	EOOO	KOOO	EOOD
Income from:
Donations &Legaoes			2,346		0	2,349	1,567
Grants		2.4		70		70	258
Charitable Activities			92			92	69
Other Trading Activities
Investments		9,3	77			81	83
Total Income			2,523	75	0	2,598	1,983
Expenditure on:
Raising Funds			(56)		0	(59)	(24)
Charitable Activities			(1,121)	(72)	0	(1,193)	(824)
Total Expenditure		7	(1,170)	(73)	0	(1,252)	(846)
Net Gain on investments		9.1	79	8	0	87	412
Net Income I(Expenditure)			1,423	10	0	1,433	1,547
Transfer between funds			0	0	0	0	0
Net movement in funds			1,423	10	0	1,433	1,547
Reconciliation ofFunds:
Total funds brought	forward		6,796	167	159	7,122	5,575
Total funds carried forward		13	8,219	177	159	8,555	7,122

						Total	Total
	Notes	Unrestricted	Restricted	Endowment		2022	2021
		Funds	Funds	Funds		Funds	Funds
		6000	6000	6000		6000	6000
Non currant assets
Investments	9.1,9.2	3,648	142	0		3,790	3713
Total non-current assets		3,648	142	0		3,790	3,713
Current assets
Trade and other receivables	10	35		0		35	27
Cash and cash equivalents		5,109	105	159		5,373	3,531
Total current assets		5,144	105	159		5,408	3,558
Current liabilities
Trade and other payables	12	(573)	(70)	0		(643)	(149)
Net current assets		4,571	35	159		4,765	3,409
Total net assets		8,219	177	159	.	8,555	7,122
Retained funds ofthe Charity
Endowment Funds Restricted Income Funds Unrestricted Income Funds	13.1 13.3 13.5	0 0 8,219	0 177 0	159 0 0		159 177 8,219	159 167 6,796
Total retai'ned funds ofthe Charity		8,219	177	159		8,555	7,122

					(Restated)
			Year Ended		Year Ended
			31 March 22	.	31 March 21
			f'000s		E'000s
Net income and expenditure for the reporting		period	1,433		1,547
(Increase)/Decrease in current debtors			(8)		5
Investment income received			(81)		(83)
Net Gain on investments revaluation			(87)		(412)
Increase / (Decrease) in current creditors			494		(598)
Net cash inflow/(ouNow)	from operating	activities	1,751		459
Disposal at sale proceeds	values		219		677
Acquisitions at cost			(209)		(716}
Investment income received			81		83
Net cash inflow/(outflow)	from investment	activities	91		44
Net cash inflow/(outflow)	cash and cash	equivalents	1,842		503
Cash and cash equivalents	at beginning	ofthe period	3,531		3,028
Cash and cash equivalents	at end ofthe	period	5,373		3,531

Income from	Income from	2								Tt(tat	Total
donations	tt						Unrestricted	Restricted	Endowment	2022	2021
legacies							Funds f000	Funds f000	Funds ,f000	Funds f000	Funds f000
		2.1	Donations
			Donations	from individuals			213			214	162
			Donations	from charities			4			4	24
			Corporate	donations			2,016			2,016	1,265
			Non corporate donations				12			12	6
							2,245			2,246	1,457
			Analysis ofdonations			from individuals	f000	received	Number ofdeposits
							2022	2021	2022	2021
			Individuals	giving	&f1k		78	38	26	16
			Individuals	giving	&f100		78	67	249	211
			Fundraising	- voluntary		(not via STSFT)	50	21	14	50
			Other				8	36	200	363
			Totals				214	162	489	640
										Total	Total
							Unrestricted	Restricted	Endowment '	2022	2021
							Funds	Funds	Funds	Funds	Funds
							f000	f000	f000	f000	f000
		2.2	Legacies
			Rehab and	Elderly	Medicine		0			0	40
			Medical Specia0ies				100			100	42
			Ophthalmology				3			3	22
			CardioThoracic Medicine				0			0	4
			General Purposes				0			0	2
							103		0	103	110

	Medical Specia0ies Ophthalmology CardioThoracic Medicine General Purposes 100 3 0 0 103	Medical Specia0ies Ophthalmology CardioThoracic Medicine General Purposes 100 3 0 0 103	Medical Specia0ies Ophthalmology CardioThoracic Medicine General Purposes 100 3 0 0 103	Medical Specia0ies Ophthalmology CardioThoracic Medicine General Purposes 100 3 0 0 103		100 3 0 0 0 103	100 3 0 0 0 103	42 22 4 2 110
	In total 6 legades were received during 2021/22, ofwhich 2 are residuary				sums	received re prior years
	(2021/22: 10).
2.3	Total donations and legacies		2,348			0	2,349	1,567
							Total	Total
			Unrestricted	Restricted		Endowment	2022	2021
			Funds	Funds		Funds	Funds	Funds
2.4	Grants		fOOO	f000		f000	f000	f000
	Grants from Charities
	Red Sky Foundation				70		70	0
	NHS CT - NHS Charities Together				0		0	198
	CHSA —Covid19 Healthcare	Support Appeal			0		0	00
							70	258

Income from		3					Total	Total
charitable				Unrestricted	Restricted	Endowment	2022	2021
activities				Funds f000	Funds f000	Funds f000	Funds '6000	Funds f000
			Course end conference fees	92			92
			8different course types were held (2021/22: 6).
Income from		4					Total	Total
other trading	.			Unrestricted	Restricted	End&a/rment	2022	2021
activities				Funds	Funds	Funds	Funds	Funds
				f000	f000	f000	6000	f000
			Staff lottery	6 i	0

Details of	5													Total	Total
Fundralslng								Unrestricted	Restricted	Endowment				2022	2021
expenditure								Funds	Funds		Funds			Funds	Funds
								f000	f000			f000		5000	f000
		Bought-in services from			NHS			(35)	0					(35)	(2)
		Investment	Broker fee					(19)	(1)					(20)	(19)
		Corporate Fundraising			non pay			(4)	0					(4)	(3)
								(58)	(1)				9	(59)	(24)
		AI traded investment		business		covering	all funds is handled		by the Charity's	investment		broker, Rathbone Investment
		Management	Ltd.
		Bought-in services relate to salary recharges from STSFTin respect ofmanaging equivalent) and the corporate charity fundraiser postf33k (075wte - leaver end									the staff December		lottery 52k (0.09wte- whole tirr 2021).
Oetags of														Total	Total
Charitable								Unrestncted	Restricted	Endowment				2022	2021
activities								Funds	Funds		Funds			Funds	Funds
expenditure	6.1	Cost ofChantable Activities						f000	f000			f000		f000	f000
		Patients' welfare and		amemtie's				(238)	0					(238)	(231)
		Course and	conference		costs			(65)	0					(65)	(39)
		Contributions	to NHS					(574)	P2)					(648)	(464)
		Staff welfare	and amenities					(176)	0					(176)	(41)
		Support and	governance		costs			(66)	0					(88)	(49)
								(1,121)	P2)				0	(1,193	(824)
Analysis of	6.2					Staff / Patient		Course and						Tots I	Total
support costs						Welfare	and	Conference	Governance					2022	2021
expenditure						Amenities		Costs	Costs		Research			Funds	Funds
		Support and	governance		cost	f000		f000	f000		f000			5000	f000
		Unrestricted					(42)	(6)	(19)					(87)	(49)
		Restricted					0	0	(1)					(1)	0
							42)	6)	(20)				0	(68)	(49)

Analysis of					Investment	Costs of
total				Costs of	Management	Charitable	Governance	Total	Total
expenditure				Fundraising	Costs	Activities	Costs	2022	2021
				5000	5000	f000	5000	5000	5000
	Other			(4)	0	(896)	0	(900)	(650)
	Bought-in services		from NHS	(35)	0	(273)	(3)	(311)	(163)
	Investment Broker fee			0	(20)	0	0	(20)	(18)
	Audit	fees - internal	audit	0	0	(4)	0	(4)	0
		provision
	Audit	fees - external	statutory					(17)	(17)
		audit provision
				(39)	(20)	(1,173)	(20)	(1,252)	(848

						2022	2021
						Total	Total
						f000	f000
Managed Porffolios
Market value at	1 April					2,570	2,104
Less: Disposals	at	Sales	Proceeds		values	(219)	(677)
Add: Acquisitions	at cost					209	716
Net unrealised and		realised gain		/ (loss) on sale and revaluation		169	427
Market value at	31	March				2,729	2,570
Fixed Interest Fund	Holding
Market value at	1 April					1,143	1,158
Lese: Disposals	at	Sales	Proceeds		values	0	0
Add: Acquisitions	st cost					0	0
Net unrealised and		realised gain		/ (loss) on sale and revaluation		82	15
Market value at	31	March				1,081	1,143
Total non current asset Investments						3,790	3,713
Historic cost at 31 March-Managed					Porffolios and Fixed Interest Holding	4,221	4,139
Traded Non Current Asset Investments:						31March	31 March
						2022	2021
						Total	Total
						8000	f000
nveshneiits Octad		n	is		Sto k Exchan s
In the UK						2,045	2,091
Outside the UK						183	60
Unlisted securities:
In Ihe UK						1,050	1,041
Outside the UK						512	521
Total						3,790	3,713
Total gross income:						2022	2021
						Total	Total
						f000	f000
Invastmerits listed on a reco nised					Stock Exchan e'
In the UK						62	65
Outside the UK						0	0
Unlisted secor/ties:
In the UK						11	11
Outside the UK						8	6
Investments in a	Common		Deposit		Fund
Current account	/ short term interest
Total						81	83

Analysis of	10	Amounts falling due within	one year:	one year:					31 March		31 March
Trade and other									2022		2021
Receivables									5000		8000
		Trade receivables							9		11
		Amounts due from STSFT							1		1
		Prepayments and accrued		income					25		15
		Total receivables falling	due	within	one year				35		27
Analysis of	11	Cash and cash equivalents							$1 INarch		31 March
Cash and Cash									2022		2021
Equivalents									f000		6000
		Cash at commercial bank and GBS							4,849		2,997
		Notice Deposits (less than		3months)					463		463
		Cash held in dealing account with			Investment	Broker			61		71
		Total cash and cash equivalents							5,373		3,531
Analysis of	12	Amounts falling due within	one year:						31 March		31 March
Trade and other									2022		2021
Payables									'8000		2000
		Amounts due to STSFT							(583)		(85)
		Trade payablas							(49)		(30)
		Accruals and deferred	income						11
		Total payables falling due within one year							(643)		(149)
Analysis of	13
Funds
	13.1	Endowment Funds	Balance								Balance
Details of				1 April					Gains on	Gains on	$1 March
material				2022	Income		Expenditure	Transfers	Disposals	Revaluations	2022
funds-				8000	FOOO		8000	8000	8000	6000	8000
Endowment
Funds		Fund 1910Legacy Fund 1900Legacy		157'2				0 0	0 0		157 2
		Funds1920-1940 Gifts		1				0	0		1
		Total		159		0	0	0	0	0	159

NOTES TO	THE FINANCIAL STATE	THE FINANCIAL STATE	MENTS	(CON	TINUE	D)
Analysis of	13(Continued)
Funds
Detaifa of	13.3	Restricted Funds				Balance										Balance
material						1 April								Gains on	Gain on	31March
funds-						2022	Income	Expenditure			Transfers			Dispossls	Revaluation	2022
Restricted						f000	f000			EOOO			f000	f000	EOOO	f000
Funds		Idaterial funds
		Leukaemia Research	Legacy			97	5			(2)						107
		Orthopaedics bequest				35	0			0						36
		Neonatal Unit Legacy				13	0			0						13
		Other designated funds				22	70			(71)						21
		Total					70			P3
	13.4	Description offunds
		Leukaemia Research	Legacy				For leukaemis	and		lymphoma	research.
		Orthopsedics bequest					For the provision		ofan operating			theatre		bed specifically designed
							for people suffering			from curvature			ofthe	spine
		Neonatal Unit legacy					For South Tynesids			neonetes
Details of	13.5	Unrestricted Funds
material						Balance										Balance
funds-						1 April								Net Gain on	Net Gain on	31March
Unrestrlcted						2022	Income	Expenditure			Transfers			Disposals	Revaluation	2022
Funds						. f000	f000			EOOO			f000	EOOO	EOOO	EOOO
		Material funds
		Medical Equipment	purposes			1618	2,021			(330)			0	24		3,333
		NeoNatal Unit				315	82			(7)			0	4		394
		COVID 19				536	6			(209)			0	8		339
		Paediatric department				335	6			P)			0	4		330
		General Purposes				430	35			(153)			0	5		317
		Rise Above Cancer				181	29			(42)			0	2		170
		SRH ICCU				47	111			(I)			0	1		150
		Glaucoma purposes				153	2			(10)			0	2		147
		Maternity Unit				138	2			(2)			0	2		140
		SRH Coronary Care				167	4			(99)			0	2		74
		Phoenix Unit - Chemotherapy				111	17			1			0	2		131
		Clinical Haemstology				123	5			(11)			0	2		119
		SEIGeneral Purposes				104	10			(60)			0	3		57
		Diabetes purposes	Legacy			09	1			(I)			0	1		90
		Renal purposes				74	14			(1)			0	1		88
		SRH Ward D45 Stroke (prev		ESB,D41)		89	5			(8)			0	1		87
		Pharmacy department				75	6			&1)			0	1		01
		Orthopaedic Department				66	2			(16)			0	1		73
		SIDH Cardiology bequests				65	1			O)			0	1		66
		South Tyneside Community		Planned	Car	58	10			&3)			0	0		65
		Raif Lottery				62	12			(11)			0	1		64
		ENT/SALT purposes				61	1			O)			0	I		62
		ALS course - resuscitation				45	49			(33)			0	I		62
		Elderly Medicine wards				75	1			(16)			0	1		59
		SRH Cardiology				57	1			(1)			0	I		58
		Gynaecology purposes				54	1			(3)			0	0		52
		Thoradc Medicine				50	2			(1)			0	1		52
		Other				1598	87			(150)			0	0		1,543
		Total Unrestricted	Funds			0,796	2,523			1,179)			0	71	8	0,219